These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11570617)

  • 1. Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure.
    Corren J; Spector S; Fuller L; Minkwitz M; Mezzanotte W
    Ann Allergy Asthma Immunol; 2001 Sep; 87(3):211-7. PubMed ID: 11570617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge.
    Phipatanakul W; Eggleston PA; Conover-Walker MK; Kesavanathan J; Sweitzer D; Wood RA
    J Allergy Clin Immunol; 2000 Apr; 105(4):704-10. PubMed ID: 10756219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
    Pearlman DS; Ostrom NK; Bronsky EA; Bonuccelli CM; Hanby LA
    J Pediatr; 1999 Mar; 134(3):273-9. PubMed ID: 10064661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
    Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
    Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
    J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
    Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
    Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.
    Perry TT; Corren J; Philip G; Kim EH; Conover-Walker MK; Malice MP; Massaad R; Dass SB; Reiss TF; Wood RA
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):431-8. PubMed ID: 15562881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma.
    Westbroek J; Pasma HR
    Respir Med; 2000 Feb; 94(2):112-8. PubMed ID: 10714415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
    Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
    Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ; Hanby LA; Lavins BJ; Simonson SG
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of clinical trials with zafirlukast.
    Calhoun WJ
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
    Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis.
    Pullerits T; Praks L; Skoogh BE; Ani R; Lötvall J
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1814-8. PubMed ID: 10351924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
    Liu YC; Khawaja AM; Rogers DF
    Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
    Kelloway JS
    Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.
    Roquet A; Dahlén B; Kumlin M; Ihre E; Anstrén G; Binks S; Dahlén SE
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1856-63. PubMed ID: 9196086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
    Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
    Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.